MCAZ Guideline on Biowaivers – Appendix I

3 days ago

#MedSafetyWeek turns 10! 🎉Since 2016, we’ve partnered with pharmacovigilance and patient safety stakeholders worldwide for #MedSafetyWeek – a campaign to raise awareness and encourage reporting of side effects. From preventing side effects to polypharmacy, children and pregnancy, the roles of patients and healthcare professionals, and more, each campaign theme has addressed a pertinent topic related to the safety of medicines and vaccines.But the campaign wouldn’t be what it is today without the unwavering support from our partners and enthusiastic audiences worldwide. THANK YOU for helping transform #MedSafetyWeek into the global campaign it is today 🙌What is your favourite #MedSafetyWeek moment throughout the years? Let us know in the comments 💬 ... See MoreSee Less

Video

View on Facebook

Medicines Control Authority of Zimbabwe

3 days ago

How can you be a #MedSafetyHero?Every patient or patient carer has the power to make medicines safer for all. Here are 4 ways that you can be more vigilant in the use of medicines and help raise awareness of #pharmacovigilance:✔️ Talk to your healthcare professional about the potential side effects of a medicine✔️ Ask your healthcare professional how and where you can report suspected side effects✔️ Read the patient information leaflet supplied with the medicine and follow the dosage instructions✔️ Tell your healthcare professional about suspected side effects and report them to primaryreporting.who-umc.org/ZWEvery report submitted to primaryreporting.who-umc.org/ZW counts when it comes to the safety of medicines and patients worldwide.Join the #MedSafetyWeek cause – #ReportSideEffects 👉 primaryreporting.who-umc.org/ZW ... See MoreSee Less

Video

View on Facebook

Medicines Control Authority of Zimbabwe

4 days ago

#MedSafetyHero #MedSafetyWeek ... See MoreSee Less

Call Now

Photo

View on Facebook

MCAZ Guideline on Biowaivers – Appendix I

QUICK LINKS

FACEBOOK FEED

Medicines Control Authority of Zimbabwe

X FEED

CONTACT US